MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directorySynapse Medicine AI solution for pharmacovigilance that helps code adverse event reports with MedDRA terms and prioritize cases by severity.
Teams handling adverse drug reaction reports or integrating medication-safety decision support into prescribing and pharmacovigilance workflows.
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Synapse Medication Shield as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the exact module and jurisdiction because Synapse materials reference pharmacovigilance automation, e-prescribing, CE-marked medical-device components, HAS certification, and ONC-certified Synapse Prescribe disclosures. |
|---|---|
| Privacy | Review anonymization, HDS hosting, GDPR posture, PHI export, adverse-event report content, patient identifiers, integration logs, retention, and cross-border transfer constraints. |
| Evidence | Check published validation of adverse-event coding, local MedDRA mapping performance, severity prioritization, expert override rates, and downstream reporting quality. |
| Workflow | Best governed as expert-reviewed pharmacovigilance or prescribing-safety support with clear queues, override documentation, regulatory reporting ownership, and post-deployment performance monitoring. |
Synapse Medicine describes Medication Shield as an artificial intelligence solution for pharmacovigilance that uses NLP to code adverse drug event reports with MedDRA terminology and prioritize them by severity; related materials describe ANSM/CRPV collaboration, data-protection posture, Synapse Prescribe AI-driven e-prescribing support, and ONC certification disclosures.
Not for: Replacing pharmacovigilance experts, unsupervised adverse-event triage, or prescribing decisions without validated local modules and clinician review.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.